Asthma, Child, Breathing Exercises
Conditions
Keywords
Asthma, Physical Therapy Specialty, Breathing Exercises, Child, Clinical Trail
Brief summary
This study has the aim to assess the effectiveness of the Buteyko method as an adjunct therapy in the treatment of children with asthma.
Detailed description
Children from 7 to 12 years old with asthma diagnose will be included. Children in the intervention group will perform 6 sessions (twice a week) of treatment with the Buteyko Method. Children assigned to the control group will receive, along with their parents, educational interventions in relation to asthma. The investigators will assess quality of life by the PAQLQ (Paediatric Asthma Quality of Life Questionnaire), pulmonary function (spirometry) and the six-minute walk test. Vital signs, pulmonary auscultation and oxygen peripheral saturation will also be assessed during the tests. In addition, information will be collected on the numbers of hospitalizations, occurence of absence in school due to exacerbation of the disease, asthma symptoms and Beta2-agonists usage .
Interventions
OTHERButeyko
Intervention will be held twice a week during 3 weeks.
OTHERAsthma education
Educational interventions in relation to asthma will be given to children assigned to the control group.
Sponsors
Universidade Federal do Rio Grande do Norte
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
7 Years to 12 Years
Healthy volunteers
No
Inclusion criteria
* Children from 7 up to 12 years old with asthma diagnose; * Regular inhaled corticosteroids with no change in dose in the preceding 4 weeks; * Children cannot present: other respiratory disease (such as cystic fibrosis, bronchiectasis, tuberculosis), retinal detachment, hypertensive crisis, congenital heart defect, pulmonary edema, history of lobectomy or lung segmentectomy, respiratory infections 15 days prior to the evaluations.
Exclusion criteria
* Children that are not able to perform some of the necessary procedures; * Give up participating in the research and present acute symptoms of respiratory tract during the assessments.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change in Quality of life (questionnaire) | Baseline and three weeks later | Quality of life will be assessed by the Pediatric Asthma Quality of Life Questionnaire (PAQLQ). |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Change in pulmonary function (spirometry) | Baseline and three weeks later | Measured parameters (which will be expressed as percent predicted): FVC, FEV1, FEV1/FVC, FEF25-75%, PEF. PEF will be expressed as L/min. |
| Change in the Six-minute walk test distance | Baseline and three weeks later | — |
| Number of visits to the emergency room | Through study completion, an average of three weeks | — |
| Occurrence of absences in school | Through study completion, an average of three weeks | — |
| Occurrence of exacerbations | Through study completion, an average of three weeks | Occurrence of asthma exacerbations or allergy episodes |
| Occurrence of Beta2-agonists usage | Through study completion, an average of three weeks | — |
Countries
Brazil
Outcome results
None listed